Anpario plc (AIM:ANP)

Market Cap	114.35M +21.6%
Revenue (ttm)	47.18M +23.5%
Net Income	6.75M +64.2%
EPS	0.38 +55.4%
Shares Out	20.42M
PE Ratio	14.76
Forward PE	13.35
Dividend	0.13 (2.23%)
Ex-Dividend Date	Jul 9, 2026

Volume	8,573
Open	560.11
Previous Close	560.00
Day's Range	550.00 - 570.00
52-Week Range	370.00 - 580.00
Beta	1.02
Analysts	Strong Buy
Price Target	598.00 (+6.93%)
Earnings Date	Jun 10, 2026

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 162
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2025, Anpario's revenue was 47.18 million, an increase of 23.51% compared to the previous year's 38.20 million. Earnings were 6.75 million, an increase of 64.20%.